Tutorials
DHA:BEACONPHAR (Bangladesh)  
Beacon Pharmaceuticals Ltd logo

Beacon Pharmaceuticals Ltd

BDT 245.00 (-0.08%) Aug 11
P/E:
60.51
P/B:
9.70
Market Cap:
BDT 56.59B ($ 595.78M)
Enterprise V:
BDT 59.95B ($ 631.13M)
Volume:
12.88K
Avg Vol (2M):
48.63K
Volume:
12.88K
Market Cap BDT:
56.59B
Market Cap $:
595.78M
PE Ratio:
60.51
Avg Vol (2-Month):
48.63K
Enterprise Value BDT:
59.95B
Enterprise Value $:
631.13M
PB Ratio:
9.70
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Beacon Pharmaceuticals Ltd
NAICS : 325412 SIC : 2834
9/B/2, Toyenbee Circular Road, Motijheel C/A, Beacon Business Centre, Dhaka, BGD, 1223
Description
Beacon Pharmaceuticals Ltd manufactures and markets pharmaceuticals products. Its products are used in various therapeutic areas, such as anticancer, cardiovascular, gastrointestinal, antibiotics, anti-coagulants, protein supplements, and muscle relaxant. The company exports its products to Europe, America, Australia, Africa, and Asia.
Name Current Vs Industry Vs History
Cash-To-Debt 0.06
Equity-to-Asset 0.59
Debt-to-Equity 0.61
Debt-to-EBITDA 2.28
Interest Coverage 6.31
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 10.45
Distress
Grey
Safe
Beneish M-Score -1.45
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 33.28
9-Day RSI 39.03
14-Day RSI 39.98
6-1 Month Momentum % 10.28
12-1 Month Momentum % 27.48

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.58
Quick Ratio 1.16
Cash Ratio 0.06
Days Inventory 169.94
Days Sales Outstanding 106.87
Days Payable 1.09

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil BDT) 6,976.487
EPS (TTM) (BDT) 4.049
Beta 0
Volatility % 24.49
14-Day RSI 39.98
14-Day ATR (BDT) 7.561819
20-Day SMA (BDT) 250.095
12-1 Month Momentum % 27.48
52-Week Range (BDT) 200 - 307
Shares Outstanding (Mil) 231

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Beacon Pharmaceuticals Ltd Filings

Document Form Filing Date
No Filing Data